 | • レポートコード：MRC2012A6599 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、眼科薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。眼科薬の種類別市場規模（ジェル、アイソリューション、カプセル＆錠剤、点眼薬、軟膏）、用途別市場規模（病院、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Allergan、Regeneron、Valeant、Aerie Pharmaceuticals、Novartis、Pfizer、Santen Pharmaceutical、Genentech、Bayer、Takeda、 ・地域別グローバル市場分析 2015年-2020年 ・眼科薬の北米市場（アメリカ、カナダ、メキシコ） ・眼科薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・眼科薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・眼科薬の南米市場（ブラジル、アルゼンチン） ・眼科薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ジェル、アイソリューション、カプセル＆錠剤、点眼薬、軟膏 ・用途別分析：病院、小売薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Ophthalmology Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Ophthalmology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Ophthalmology Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Ophthalmology Drugs market has been segmented into
Gels
Eye Solutions
Capsules & Tablets
Eye Drops
Ointments
By Application, Ophthalmology Drugs has been segmented into:
Hospital
Retail Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ophthalmology Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Ophthalmology Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ophthalmology Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Ophthalmology Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Ophthalmology Drugs Market Share Analysis
Ophthalmology Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ophthalmology Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ophthalmology Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Ophthalmology Drugs are:
Allergan
Regeneron
Valeant
Aerie Pharmaceuticals
Novartis
Pfizer
Santen Pharmaceutical
Genentech
Bayer
Takeda
Among other players domestic and global, Ophthalmology Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ophthalmology Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ophthalmology Drugs, with price, sales, revenue and global market share of Ophthalmology Drugs in 2018 and 2019.
Chapter 3, the Ophthalmology Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ophthalmology Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Ophthalmology Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Ophthalmology Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Ophthalmology Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ophthalmology Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Gels
1.2.3 Eye Solutions
1.2.4 Capsules & Tablets
1.2.5 Eye Drops
1.2.6 Ointments
1.3 Market Analysis by Application
1.3.1 Overview: Global Ophthalmology Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Overview of Global Ophthalmology Drugs Market
1.4.1 Global Ophthalmology Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Regeneron
2.2.1 Regeneron Details
2.2.2 Regeneron Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Regeneron SWOT Analysis
2.2.4 Regeneron Product and Services
2.2.5 Regeneron Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Valeant
2.3.1 Valeant Details
2.3.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Valeant SWOT Analysis
2.3.4 Valeant Product and Services
2.3.5 Valeant Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Aerie Pharmaceuticals
2.4.1 Aerie Pharmaceuticals Details
2.4.2 Aerie Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Aerie Pharmaceuticals SWOT Analysis
2.4.4 Aerie Pharmaceuticals Product and Services
2.4.5 Aerie Pharmaceuticals Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Santen Pharmaceutical
2.7.1 Santen Pharmaceutical Details
2.7.2 Santen Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Santen Pharmaceutical SWOT Analysis
2.7.4 Santen Pharmaceutical Product and Services
2.7.5 Santen Pharmaceutical Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genentech
2.8.1 Genentech Details
2.8.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genentech SWOT Analysis
2.8.4 Genentech Product and Services
2.8.5 Genentech Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer SWOT Analysis
2.9.4 Bayer Product and Services
2.9.5 Bayer Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Takeda SWOT Analysis
2.10.4 Takeda Product and Services
2.10.5 Takeda Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Ophthalmology Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Ophthalmology Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Ophthalmology Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Ophthalmology Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Ophthalmology Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Ophthalmology Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Ophthalmology Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Ophthalmology Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Ophthalmology Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Ophthalmology Drugs Sales and Growth Rate (2015-2020)
4.5 South America Ophthalmology Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Ophthalmology Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Ophthalmology Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Ophthalmology Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Ophthalmology Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Ophthalmology Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Ophthalmology Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Ophthalmology Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Ophthalmology Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Ophthalmology Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Ophthalmology Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Ophthalmology Drugs Sales and Growth Rate (2015-2020)
6.3 UK Ophthalmology Drugs Sales and Growth Rate (2015-2020)
6.4 France Ophthalmology Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Ophthalmology Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Ophthalmology Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Ophthalmology Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Ophthalmology Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Ophthalmology Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Ophthalmology Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Ophthalmology Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Ophthalmology Drugs Sales and Growth Rate (2015-2020)
7.5 India Ophthalmology Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Ophthalmology Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Ophthalmology Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Ophthalmology Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Ophthalmology Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Ophthalmology Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Ophthalmology Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Ophthalmology Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Ophthalmology Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Ophthalmology Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Ophthalmology Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Ophthalmology Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Ophthalmology Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Ophthalmology Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Ophthalmology Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Ophthalmology Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Ophthalmology Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Ophthalmology Drugs Price by Type (2015-2020)
11 Global Ophthalmology Drugs Market Segment by Application
11.1 Global Ophthalmology Drugs Sales Market Share by Application (2015-2020)
11.2 Global Ophthalmology Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Ophthalmology Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Ophthalmology Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Ophthalmology Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Ophthalmology Drugs Market Forecast (2021-2025)
12.2.2 Europe Ophthalmology Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Ophthalmology Drugs Market Forecast (2021-2025)
12.2.4 South America Ophthalmology Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Ophthalmology Drugs Market Forecast (2021-2025)
12.3 Ophthalmology Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Ophthalmology Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Ophthalmology Drugs Market Share Forecast by Type (2021-2025)
12.4 Ophthalmology Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Ophthalmology Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Ophthalmology Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Ophthalmology Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ophthalmology Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ophthalmology Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Allergan Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Ophthalmology Drugs Major Business
Table 9. Allergan Ophthalmology Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Allergan SWOT Analysis
Table 11. Allergan Ophthalmology Drugs Product and Services
Table 12. Allergan Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Regeneron Basic Information, Manufacturing Base and Competitors
Table 14. Regeneron Ophthalmology Drugs Major Business
Table 15. Regeneron Ophthalmology Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Regeneron SWOT Analysis
Table 17. Regeneron Ophthalmology Drugs Product and Services
Table 18. Regeneron Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Valeant Basic Information, Manufacturing Base and Competitors
Table 20. Valeant Ophthalmology Drugs Major Business
Table 21. Valeant Ophthalmology Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Valeant SWOT Analysis
Table 23. Valeant Ophthalmology Drugs Product and Services
Table 24. Valeant Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Aerie Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 26. Aerie Pharmaceuticals Ophthalmology Drugs Major Business
Table 27. Aerie Pharmaceuticals Ophthalmology Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Aerie Pharmaceuticals SWOT Analysis
Table 29. Aerie Pharmaceuticals Ophthalmology Drugs Product and Services
Table 30. Aerie Pharmaceuticals Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Ophthalmology Drugs Major Business
Table 33. Novartis Ophthalmology Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Novartis SWOT Analysis
Table 35. Novartis Ophthalmology Drugs Product and Services
Table 36. Novartis Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Ophthalmology Drugs Major Business
Table 39. Pfizer Ophthalmology Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Ophthalmology Drugs Product and Services
Table 42. Pfizer Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Santen Pharmaceutical Ophthalmology Drugs Major Business
Table 45. Santen Pharmaceutical Ophthalmology Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Santen Pharmaceutical SWOT Analysis
Table 47. Santen Pharmaceutical Ophthalmology Drugs Product and Services
Table 48. Santen Pharmaceutical Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Genentech Basic Information, Manufacturing Base and Competitors
Table 50. Genentech Ophthalmology Drugs Major Business
Table 51. Genentech Ophthalmology Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Genentech SWOT Analysis
Table 53. Genentech Ophthalmology Drugs Product and Services
Table 54. Genentech Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bayer Basic Information, Manufacturing Base and Competitors
Table 56. Bayer Ophthalmology Drugs Major Business
Table 57. Bayer Ophthalmology Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Bayer SWOT Analysis
Table 59. Bayer Ophthalmology Drugs Product and Services
Table 60. Bayer Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Takeda Basic Information, Manufacturing Base and Competitors
Table 62. Takeda Ophthalmology Drugs Major Business
Table 63. Takeda Ophthalmology Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Takeda SWOT Analysis
Table 65. Takeda Ophthalmology Drugs Product and Services
Table 66. Takeda Ophthalmology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Ophthalmology Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 68. Global Ophthalmology Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Ophthalmology Drugs Sales by Regions (2015-2020) (K Units)
Table 70. Global Ophthalmology Drugs Sales Market Share by Regions (2015-2020)
Table 71. Global Ophthalmology Drugs Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Ophthalmology Drugs Sales by Countries (2015-2020) (K Units)
Table 73. North America Ophthalmology Drugs Sales Market Share by Countries (2015-2020)
Table 74. North America Ophthalmology Drugs Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Ophthalmology Drugs Revenue Market Share by Countries (2015-2020)
Table 76. Europe Ophthalmology Drugs Sales by Countries (2015-2020) (K Units)
Table 77. Europe Ophthalmology Drugs Sales Market Share by Countries (2015-2020)
Table 78. Europe Ophthalmology Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Ophthalmology Drugs Sales by Regions (2015-2020) (K Units)
Table 80. Asia-Pacific Ophthalmology Drugs Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Ophthalmology Drugs Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Ophthalmology Drugs Sales by Countries (2015-2020) (K Units)
Table 83. South America Ophthalmology Drugs Sales Market Share by Countries (2015-2020)
Table 84. South America Ophthalmology Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Ophthalmology Drugs Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Ophthalmology Drugs Sales by Countries (2015-2020) (K Units)
Table 87. Middle East & Africa Ophthalmology Drugs Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Ophthalmology Drugs Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Ophthalmology Drugs Revenue Market Share by Countries (2015-2020)
Table 90. Global Ophthalmology Drugs Sales by Type (2015-2020) (K Units)
Table 91. Global Ophthalmology Drugs Sales Share by Type (2015-2020)
Table 92. Global Ophthalmology Drugs Revenue by Type (2015-2020) (USD Million)
Table 93. Global Ophthalmology Drugs Revenue Share by Type (2015-2020)
Table 94. Global Ophthalmology Drugs Sales by Application (2015-2020) (K Units)
Table 95. Global Ophthalmology Drugs Sales Share by Application (2015-2020)
Table 96. Global Ophthalmology Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 97. Global Ophthalmology Drugs Market Share Forecast by Regions (2021-2025)
Table 98. Global Ophthalmology Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 99. Global Ophthalmology Drugs Market Share Forecast by Type (2021-2025)
Table 100. Global Ophthalmology Drugs Sales Forecast by Application (2021-2025)
Table 101. Global Ophthalmology Drugs Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Ophthalmology Drugs Picture
Figure 2. Global Sales Market Share of Ophthalmology Drugs by Type in 2019
Figure 3. Gels Picture
Figure 4. Eye Solutions Picture
Figure 5. Capsules & Tablets Picture
Figure 6. Eye Drops Picture
Figure 7. Ointments Picture
Figure 8. Ophthalmology Drugs Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Retail Pharmacy Picture
Figure 11. Global Ophthalmology Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Ophthalmology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Ophthalmology Drugs Sales Market Share by Manufacturer in 2019
Figure 32. Global Ophthalmology Drugs Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Ophthalmology Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Ophthalmology Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Ophthalmology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Ophthalmology Drugs Revenue Market Share by Regions (2015-2020)
Figure 39. Global Ophthalmology Drugs Revenue Market Share by Regions in 2018
Figure 40. North America Ophthalmology Drugs Sales and Growth Rate (2015-2020)
Figure 41. Europe Ophthalmology Drugs Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Ophthalmology Drugs Sales and Growth Rate (2015-2020)
Figure 43. South America Ophthalmology Drugs Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Ophthalmology Drugs Sales and Growth Rate (2015-2020)
Figure 45. North America Ophthalmology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Ophthalmology Drugs Sales Market Share by Countries (2015-2020)
Figure 47. North America Ophthalmology Drugs Sales Market Share by Countries in 2018
Figure 48. North America Ophthalmology Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Ophthalmology Drugs Revenue Market Share by Countries in 2018
Figure 50. United States Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Ophthalmology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Ophthalmology Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Ophthalmology Drugs Revenue Market Share by Countries in 2019
Figure 56. Germany Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Ophthalmology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Ophthalmology Drugs Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Ophthalmology Drugs Revenue Market Share by Regions 2019
Figure 64. China Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Ophthalmology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Ophthalmology Drugs Sales Market Share by Countries in 2019
Figure 71. South America Ophthalmology Drugs Revenue Market Share by Countries in 2019
Figure 72. Brazil Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Ophthalmology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Ophthalmology Drugs Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Ophthalmology Drugs Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Ophthalmology Drugs Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Ophthalmology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Ophthalmology Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Ophthalmology Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Ophthalmology Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Ophthalmology Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Ophthalmology Drugs Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Ophthalmology Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Ophthalmology Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
眼科治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Ophthalmology Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ophthalmology Treatme…- 眼科用機器の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ophthalmology Instrumentation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ophthalmology I…
- 眼科用PACS（画像アーカイブ・通信システム）の世界市場（～2026年） Ophthalmology PACS are used in the efficient management of image data eliminating the physical constraints associated with communication of radiologic image data on film. The market is dominated by North America, followed by Europe. The dominance of the North American market is attributed to factors…
- 植物・植物由来薬剤の世界市場（～2026年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…
- ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…